Aflibercept 8 mg versus Faricimab Treat-and-Extend for Diabetic Macular Edema or Neovascular Age-Related Macular Degeneration: A Bayesian Fixed-Effect Network Meta-analysis of Clinical Trials.
Saved in:
| Title: | Aflibercept 8 mg versus Faricimab Treat-and-Extend for Diabetic Macular Edema or Neovascular Age-Related Macular Degeneration: A Bayesian Fixed-Effect Network Meta-analysis of Clinical Trials. |
|---|---|
| Authors: | Friedman, Scott M.1 (AUTHOR) smfriedman83@hotmail.com, Xu, Yingxin2 (AUTHOR), Sherman, Steven2 (AUTHOR), Kuznik, Andreas2 (AUTHOR), Mojebi, Ali3 (AUTHOR), Keeping, Sam3 (AUTHOR), Chan, Keith3 (AUTHOR), Leng, Theodore4 (AUTHOR), Patel, Nimesh5,6 (AUTHOR) |
| Source: | Ophthalmology & Therapy. Nov2025, Vol. 14 Issue 11, p2919-2936. 18p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 21938245 |
|---|---|
| DOI: | 10.1007/s40123-025-01247-3 |
